What is Bristol-Myers Squibb's common stock?

Bristol-Myers Squibb (BMY) reported common stock of $292M in Q1 2026.

How has Bristol-Myers Squibb's common stock changed year-over-year?

Bristol-Myers Squibb's common stock decreased by 0.0% year-over-year, from $292M to $292M.

What is the long-term trend for Bristol-Myers Squibb's common stock?

Over 5 years (2020 to 2025), Bristol-Myers Squibb's common stock has grown at a 0.0% compound annual growth rate (CAGR), from $292M to $292M.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Bristol-Myers Squibb BMY Common Stock

Common Stock at other companies

Johnson & JohnsonJNJ

$3.12B—

IncyteINCY

400M0.0%

Oruka Therapeutics, Inc.ORKA

545M0.0%

Neurocrine BiosciencesNBIX

220M0.0%

CytokineticsCYTK

$124K+4.2%

ImmunityBio, Inc.IBRX

1.7B+22.2%

Other financials

Income statement

See full

Revenue$11.5B+2.6%

Gross profit$8.1B-1.2%

Net income$2.7B+9.0%

EPS (diluted)$1.31+9.2%

Balance sheet

See full

Cash & equivalents$9.6B-12.0%

Total debt$44.7B-10.5%

Total equity$20.1B+15.4%

Total assets$86.5B-6.4%

Cash flow

See full

Operating cash flow$1.1B-43.5%

CapEx$347.0M+33.5%

Free cash flow$757.0M-55.3%

Valuation

See full

Market cap$125.61B+26.1%

Enterprise value$160.69B+17.8%

P/E17.3×-2.7×

P/S2.6×+0.5×

Profitability

See full

Gross margin70.5%0.0pp

Net margin15%+3.8pp

FCF margin24.6%-2.9pp

Returns & leverage

See full

Return on equity38.8%+7.3pp

Debt / equity2.2×-0.6×

Current ratio1.4×+0.1×

Where this comes from

Reported directly by Bristol-Myers Squibb in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValueOutstanding.

The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bristol-Myers Squibb's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bristol-Myers Squibb's common stock?: Bristol-Myers Squibb (BMY) reported common stock of $292M in Q1 2026.
How has Bristol-Myers Squibb's common stock changed year-over-year?: Bristol-Myers Squibb's common stock decreased by 0.0% year-over-year, from $292M to $292M.
What is the long-term trend for Bristol-Myers Squibb's common stock?: Over 5 years (2020 to 2025), Bristol-Myers Squibb's common stock has grown at a 0.0% compound annual growth rate (CAGR), from $292M to $292M.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).